We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MS

News List

Novartis real-world data at AAN confirms benefit of Gilenya® on four key measures of disease activit worldpharmanews
April 25, 2017
Novartis today announced data from the Phase IV Multiple Sclerosis and clinical outcome and MRI in the US (MS-MRIUS) study, which confirmed the effectiveness of Gilenya® (fingolimod) in the real-world setting, supporting previous findings from Phase III t
Immune-Based Therapy Shows Early Promise Against MS drugs.com
April 21, 2017
An experimental immune-system therapy appears safe for people with progressive forms of multiple sclerosis. And it may ease symptoms in some, a preliminary study suggests.

Previous page 1 2 3 4 5 6 7 8 9 Next page